Education

Biography

Nahrevanian is working at the Department of Parasitology, Pasteur Institute of Iran from 1989 and his current position is head of parasitology and immunology group as a Professor. He got his BSc in Biology (Animal Sciences), (1985), MSPH in Medical Parasitology, (1993) and PhD in Clinical Parasitology, (2001) from the School of Biological Sciences, Faculty of Medicine, the University of Manchester, UK. His research experiences and skills are: Immunoparasitology, serology, Cell culture, Tissue preparation, Histopathology, Pharmacology, Immunoflourescence, Colorimetric and protein analysis assays, RNA & DNA extraction, RNA-transcription, PCR, RT-PCR, RFLP, Sequencing, ELISA, Flow cytometry, Western blotting etc, UK home office license holder for animal working, Molecular biology (Proteomics, Genomics), Bioinformatics tools, Statistics software (SPSS, Graph Pad Prism), Photoshop, Animation Software, internet-searching, Web-design, Scientific Web Indexes (Magiran, SID, Iran Doc, Iran Medex, Scirus, ISI, Scopus, Index Copernicus, Bio Med Experts, Google Scholar,.).

Research Interest

• Immunoparasitology and molecular epidemiology of intracellular protozoan parasites

Scientific Activities

Employment History

Professional Activities

• Member, Korean Society for Parasitology Since 2009
• Member, Biosafety Society of Iran Since 2007
• Member, Iranian Society for Immunology & Allergy Since 2004
• Member, Iranian Society for Biotechnology Since 2002
• Member, British Society for Parasitology Since 1998
• Member, Iranian Society for Parasitology Since 1997

HONORS AND AWARDS

• Travel Grant, (Euros 1,000), 19th United European Gastroenterology Week (19th UEGW), October 22-26, Stockholm, Sweden (2011)
• Travel Award, (JY 30,000), 6th International Conference on the Biology, Chemistry & Therapeutic Applications of Nitric Oxide, Kyoto, Japan (2010)
• AGD Prize, as Shortlisted abstracts (RMB 1,000), 3rd Ditan International Conference on Infectious Diseases, Beijing, China (2009)
• Project grant, (USD 10,000) for project No. 353, Centre for Diseases Control of MOHME (2008-10)
• Co-Projects grants, for projects Parand Islamic Azad University, Mash-had UMS (No. 86780), Tehran UMS, Ahvaz UMS (2006-10)
• Projects grants, for projects numbers 200, 212, 237, 308, 318, 352, 353, 451, 584, 613 Pasteur Institute of Iran, Tehran, Iran (2003-12)
• Full scholarship to study for a PhD degree in Molecular Parasitology at the University of Manchster, awarded by Iran Ministry of Health and Medical Education (1996-2000)
• Co-Projects grants, for projects numbers 1, 2, 49, 81, 220, 229, 368, 388, 394, 434, Pasteur Institute of Iran, Tehran, Iran (1986-2010)

Publications

1. Papizadeh M, Rohani M, Nahrevanian H, Javadi AR, Pourshafie MR. Probiotic characters of Bifidobacterium and Lactobacillus are a result of the ongoing gene acquisition and genome minimization evolutionary trends. Microbial Pathogenesis, 2017.
2. Esfandiari B, Nahrevanian H, Pourshafie MR, Gouya MM, Khaki P, Mostafavi E, Darvish J, Hanifi H. Epidemiological distribution of rodents as potent reservoirs for infectious diseases in the provinces of Mazandaran, Gilan and Golestan, northern Iran. Infectious Disease Reports, 2017; 9(2):6900.
3. Miandoabi T, Hazrati Tappeh K, Nahrevanian H, Kazemi SM, Mohammadzadeh H, Hanifian H. Pharmacochemistry of Iranian Flora Artemisia oliveriana and its Antimalarial Effects on Plasmodium berghei in Vivo. Advanced Studies in Biology, 2017;  9(1): 43-51.
4. Papizadeh M, Nahrevanian H, Rohani M, Hosseini SN, Shojaosadati SA. Lactobacillus rhamnosus Gorbach-Goldin (GG): A Top Well-Researched Probiotic Strain. Journal of Medical Bacteriology, 2016; 5(5-6): 46-59.  
5. Haniloo A, Nemati S, Nahrevanian H, Fazaeli A, Farahmand M. In vivo and in vitro investigation on anti-leishmanial efficacy of artemisinin on Iranian strain of Leishmania major. Advanced Studies in Medical Sciences, 2016; 4(1): 1-11.
6.  Naderi S, Nahrevanian H, Khalaj V, Farahmand M. Cloning, expression and purification of recombinant A2 protein from Leishmania infantum for diagnosis of visceral leishmaniasis in Iran. Advanced Studies in Biology, 2016; 8(3): 101-110.
7. Modaresinejad M, Nahrevanian H, Khatami S, Bagheri E. Biochemical association between essential trace elements and susceptibility to malaria in outbred mice after inhibition with dexamethasone or induction with lipopolysaccharide. Advanced Studies in Biology, 2016; 8(2): 91-99.
8. Esfandiari B, Nahrevanian H, Pourshafie MR, Gouya MM, Khaki P, Mostafavi E, Darvish J, Moradi Bidhendi S, Hanifi H, Gharakhani M. Association of prevalent Leptospira species with different rodents of three Northern Provinces in Iran using microscopic agglutination test. Advanced Studies in Biology, 2016; 8(2); 53-63.
9. Farahmand M, after Nahrevanian H. Application of recombinant proteins for sero-diagnosis of visceral leishmaniasis in human and dogs. Iranian Biomedical Journal, 2016; 20(3): 135-144.
10. Modaressinejad M, Nahrevanian H, Khatami S. Immunobiochemical study of host during malaria infection via nitric oxide pathway after modulation by lipopolysaccharide and dexamethasone in mice model. International Journal of Biological Chemistry, 2015; 9(5): 260-268.
11. Faezi F, Nahrevanian H, Farahmand M, Sayyah M, Bidoki SK, Nemati S. Partial immunotherapy of leishmaniasis by in vivo trial of L-arginine in Balb/c mice infected with Leishmania major via nitric oxide pathway. International Journal of Biological Chemistry, 2015; 9(3): 110-122.
12. Nahrevanian H, Assmar M, Zahraei SM, Mafi M, Masoumi Asl H, Ghasemi FS. Prevalence of sporozoan protozoa and enteroparasites in the gastroenteritic patients referring to the healthcare centers of seven provinces of Iran. International Journal of Enteric Pathogens, 2015; 3(3): 19-24. e27087.
13. Ghaffarinejad P, Farahmand M, Nahrevanian H, Mohebali M, Zaboli F, Zarei Z, Akhoundi B, Barati M, Ghasemi FS. Diagnosis of Leishmania infantum using direct agglutination test and rKE16 dipstick rapid test in domestic dogs from Ardabil Province, Iran. Research Journal of Parasitology, 2015; 10(3):102-110.
14. Rustaiyan A, Nahrevanian H, Zamani Z, Taherkhani M, Iravani A. An Investigation on Anti-malarial Effects of Tehranolide Isolated from Artemisia diffusa Against Human Malaria Parasite, Plasmodium falciparum in vitro. Research Journal of Parasitology, 2015; 10(2):73-78.
15. Farahmand M, Khalaj V, Mohebali M, Khalili G, Naderi S, Nahrevanian H, Ghaffarinejad P. Comparison of recombinant A2-ELISA with rKE16 dipstick and direct agglutination tests for diagnosis of visceral leishmaniasis in dogs in northwestern Iran. Journal of the Brazilian Society of Tropical Medicine, 2015; 48(2):188-93.
16. Esfandiari B, Pourshafie MR, Gouya MM, Khaki P, Mostafavi E, Darvish J, Moradi Bidhendi S, Hanifi H, Nahrevanian H. An epidemiological comparative study on diagnosis of rodent leptospirosis in Mazandaran Province, northern Iran. Epidemiology & Health, 2015;;1-9. e2015012.
17. Najafzade M, Mosapour A, Nahrevanian H, Zamani Z, Javadian S, Mirkhani F. Effect of trinitroglycerin therapy on serum zinc and copper levels and liver enzyme activities in BALB/c mice infected with Leishmania major MRHO/IR/75/ER. Iranian Journal of Basic Medical Sciences, 2015; 18(3): 277-283.
18. Najafi M, Nahrevanian H, Khatami Sh, Masoudian N, Frahmand M. Investigation on bacterial lipopolysaccharide as immune system inducer on inbred Balb/c mice via nitric oxide pathway. Advanced Studies in Biology, 2015; 7(1): 1-10.
19. Nikoukar LR, Nabavizadeh F, Mohamadi SM, Moslehi A, Hassanzadeh G, Nahrevanian H, Agah S. Protective effect of ghrelin in a rat model of celiac disease. Acta Physiol Hung. 2014;101(4):438-447.
20. Esmaeili Rastaghi AR, Nedaei F, Nahrevanian H, Hoseinkhan N. Genetic diversity and effect of natural selection at apical membrane antigen-1 (AMA-1) among Iranian Plasmodium vivax isolates. Folia Parasitologica, 2014; 61(5): 385-393.
21. Moslehi A, Nabavizadeh F, Dehpou AR, Tavanga SM, Hassanzadeh G, Zekri A, Nahrevanian H, Sohanaki H. Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice. Acta Physiol Hung. 2014;101(3):341-352. Erratum: Acta Physiol Hung. 2014;101(4):524.
22. Taherkhani M, Rustaiyan A, Nahrevanian H, Salehizadeh E. In vivo antimalarial activity of Iranian flora Artemisia oliveriana J. Gay ex DC. extract and its comparison with other anti-malarial drugs against Plasmodium berghei in mice model. Journal of Biologically Active Products from Nature, 2013; 3(3): 173-182.
23. Taherkhani M, Rustaiyan A, Nahrevanian H, Naeimi S, Taherkhani T. Comparison of antimalarial activity of Artemisia turanica extract with current drugs in vivo. Journal of Vector Born Diseases, 2013; 50(1): 51-56.
24. Shahi M, Mohajery M, Shamsian SAA, Nahrevanian H, Yazdanpanah SMJ. Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis. Reports of Biochemistry & Molecular Biology, 2013; 1(2): 1-6.
25. Sadeghi Niaraki M, Nabavizadeh F, Vaezi GhH, Alizadeh AM, Nahrevanian H, Moslehi A, Azizian A. Protective effect of Ghrelin on sodium valproate- induced liver injury in rat. Journal of Stress Physiology & Biochemistry, 2013; 9(1): 96-105.
26. Sar Kheyr Kheyabany S, Nabavizadeh F, Vaezi GhH, Alizadeh AM, Nahrevanian H, Moslehi A, Azizian A. Protective effect of Ghrelin on Isoniazid-induced liver injury in rat. Journal of Stress Physiology & Biochemistry, 2013; 9(1): 273-282.
27. Ahmadi A, Sayyah M, Khoshkholgh-Sima B, Choopani S, Kazemi J, Sadegh M, Moradpour F, Nahrevanian H. Intra-hippocampal injection of lipopolysaccharide inhibits kindled seizures and retards kindling rate in adult rats. Experimental Brain Research. 2013; 226(1): 107-120.
28. Nemati S, Nahrevanian H, Haniloo A, Farahmand M. Investigation on nitric oxide and c-reactive protein involvement in anti-leishmanial effects of Artemisinin and Glucantim on cutaneous leishmaniasis. Advanced Studies in Biology, 2013; 5(1): 27-36.
29. Nahrvevanian H, Jafary SP, Nemati S, Farahmand M, Omidinia E. Evaluation of anti-leishmanial effects of Killed Leishmania Vaccine with BCG adjuvant in BALB/c mice infected with Leishmania major MRHO/IR/75/ER. Folia Parasitologica, 2013; 60(1): 1-6.
30. Nemati S, Jafary SP, Nahrevanian H, Farahmand M, Nahrevanian S. Immuno-biochemical alterations in Leishmania major infected Balb/c mice after immunization with Killed Leishmania Vaccine and BCG as adjuvant. Current Research Journal of Biological Sciences, 2012; 4(6): 706-712.
31. Zamani Z, Sadeghi Tafreshi A, Nahrevanian H, Lame-Rad B, Pourfallah F, Eslamifar H, Sadeghi S, Vahabi F, Iravani I, Arjmand M. Efficacy of Eosin B as a new anti malarial drug in a murine model. Malaria Research and Treatment, 2012; ID 381724: 1-5.
32. Sanati H, Nourollahi Fard SR, Nahrevanian H, Khalili M, Safari Z. Seroprevalence of Toxoplasma gondii antibodies in dairy cows in Kerman Province, South East Iran. Current Research Journal of Biological Sciences, 2012; 4(4): 417-421.
33. Nahrevanian H, Jalalian M, Farahmand M, Assmar M, Esmaeili Rastaghi AR, Sayyah M. Inhibition of murine systemic leishmaniasis by acetyl salicylic acid via nitric oxide immunomodulation. Iranian Journal of Parasitology, 2012; 7(2): 21-28.
34. Bahrami AM, Doosti AZ, Nahrevanian H, Shamsi M. Pathological study on parasitism in racing pigeons; An indication of its effects on community health. Advances in Environmental Biology, 2012; 6(2): 726-732.
35. Nahrevanian H, Sheykhkanlooye Milan B, Kazemi M, Hajhosseini R, Soleymani Mashhadi S, Nahrevanian S. Antimalarial effects of Iranian flora Artemisia sieberi on Plasmodium berghei in vivo to mice and phytochemistry of its herbal extracts. Malaria Research and Treatment, 2012; ID 727032: 1-8.
36. Salehizadeh E, Nahrvevanian H, Farahmand M, Hajihosseini R, Saghiri R, Khalili G: In vivo application of killed Leishmania vaccine and Imiquimod as adjuvant in Balb/c mice infected with Leishmania major MRHO/IR/75/ER as Iranian strain. Research Journal of Parasitology, 2011; 6(4): 116-126.
37. Fallahi S, Nabavizadeh F, Sadr SS, Alizadeh AM, Adeli S, Nahrevanian H, Sadeghipour HR, Hasanzadeh Gh: The effects of Leptin on gastric ulcer due to physical and psychological stress: Involvement of nitric oxide and prostaglandin E2. Journal of Stress Physiology & Biochemistry, 2011; 7(4): 301-310.
38. Bahrami AM, Doosti AZ, Nahrevanian H, Noorian AM, Ahmadi Asbchin S. Epidemiological survey of gastro-intestinal parasites in stray dogs and cats. Australian Journal of Basic and Applied Sciences, 2011; 5(9): 1944-1948.
39. Moloudi R, Nabavizadeh F, Nahrevanian H, Hassanzadeh Gh. Effect of different doses of GLP-2 (Teduglutide) on acute esophageal lesion due to acid- pepsin perfusion in male rats. Peptides, 2011; 32(10): 2086-2090.
40. Rustaiyan A, Nahrevanian H, Kazemi M. Isolation of Artediffusin (Tehranolide) as a new antimalarial agent. Asian Journal of Chemistry, 2011; 23(11):4810-4814.
41. Farahmand M, Atashi Shirazi H, Nahrevanian H, Hajjaran H. Molecular analysis of A2-genes encoding stage-specific S antigen-like proteins among isolates from Iranian cutaneous and visceral leishmaniasis. Iranian Journal of Basic Medical Sciences, 2011; 14(5):407-413.
42. Nahrevanian H, Aboufazeli F, Kazemi SM, Hajihosseini R, Naeimi S: Phytochemical evaluation and antimalarial effects of Artemisia turanica herbal extracts as an Iranian flora on Plasmodium berghei in vivo. Journal of Natural Remedies, 2011; 11(2):167-176.
43. Vahedian M, Nabavizadeh F, Vahedian J, Keshavarz M, Nahrevanian H, Mirershadi F. Lead exposure changes gastric motility in rats: Role of nitric oxide (NO). Achieve of Iranian Medicine. 2011;14(4):266-269.
44. Farahmand M, Nahrevanian H, Atashi Shirazi H, Naeimi S, Farzanehnejad Z: An overview of diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran. Brazilian Journal of Infectious Diseases, 2011; 15(1):17-21.
45. Tabatabaee P, Abolhassani M, Mahdavi M, Nahrevanian H, Azadmanesh K: Leishmania major: Secreted antigens of Leishmania major promastigotes shift the immune response of the C57BL/6 mice toward Th2 in vitro. Experimental Parasitology, 2011; 127(1): 46-51.
46. Hosseini M, Sadat Dastghaib S, Rafatpanah H, Hadjzadeh M, Nahrevanian H, Farrokhi I: Nitric oxide contributes to learning and memory deficits observed in hypothyroid rats during neonatal and juvenile growth. Clinics, 2010; 65(11): 1175-1181.
47. Nabavizadeh F, Moloudi R, Dehpour AR, Nahrevanian H, Shahvaisi K, Salimi E: The Effects of cholestasis and cirrhosis on gastric acid and pepsin secretions in rat: Involvement of nitric oxide. Iranian Journal of Basic Medical Sciences, 2010; 13(4): 207-212.
48. Golestan Jahromi M, Nabavizadeh F, Vahedian J, Nahrevanian H, Dehpour AR, Zare-Mehrjardi A: Protective effect of ghrelin on acetaminophen induced liver injury in rat. Peptides, 2010; 31(X): 2114---2117.
49. Nahrevanian H, Azarinoosh SA, Esfandiari B, Ziapoor SP, Shadifar M, Amirbozorgy G, Hayati E, Davoodi J. Current situation of Cryptosporidium and other enteroparasites among patients with gastroenteritis from western cities of Mazandaran Province, Iran, during 2007-08. Journal of Gastroenterology and Hepatology from Bed to Bench, 2010; 3(3):120-125.
50. Roghani M, Mahboudi F, Saharian MA, Etemadifar M, Esfahani AN, Nahrevanian H, Elahi E: Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients. Journal of the Neurological Sciences. 2010; 294(1-2): 92-94.
51. Nahrevanian H, Esmaeili B, Kazemi M, Nazem H, Amini M: In vivo antimalarial effects of Iranian flora Artemisia khorassanica against Plasmodium berghei and pharmacochemistry of its natural components. Iranian Journal of Parasitology, 2010; 5(1): 6-19.
52. Nahrevanian H: Involvement of nitric oxide and its up/down stream molecules in the immunity of parasitic infections. Brazilian Journal of Infectious Diseases, 2009; 13(6): 440-448.
53. Davachi S, Nahrevanian H, Omidinia E, Hajihosseini R, Amini M, Farahmand M, Mirkhani F, Javadian S: Biochemical alterations of liver enzymes and microelements during Leishmania major infection in BALB/c mice after treatment with Paromomycin. Pharmacologyonline, 2009; 3: 424-436.
54. Nahrevanian H, Hajihosseini R, Arjmand M, Farahmand M, Ghasemi F: Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major. Southeast Asian Journal of Tropical Medicine and Public Health, 2009; 40(6):1188-1198.
55. Amini M, Nahrevanian H, Khatami S, Farahmand M, Mirkhani F, Javadian S: Biochemical association between the essential trace elements and susceptibility to Leishmania major in BALB/c and C57BL/6 mice. Brazilian Journal of Infectious Diseases, 2009; 13(2):83-85.
56. Sharif M, Daryani A, Rostami M, Nahrevanian H, Azadbakht M: Evaluation of antileishmanial efficacy by in vivo administration of herbal extract Artemisia auchery on Leishmania major in BALB/C mice. Pharmacologyonline, 2009; 2: 477-485.
57. Nahrevanian H, Najafzadeh M, Hajihosseini R, Nazem H, Farahmand M, Zamani Z: The therapeutic antileishmanial effects of Trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway. Korean Journal of Parasitology, 2009; 47(2): 109-115.
58. Nahrevanian H, Amini M: Nitric oxide functions; an emphasis on its diversity in infectious diseases. Iranian Journal of Basic Medical Sciences, 2009; 11(4): 197-204.
59. Esfandiari B, Fayaz A, Nahrevanian H, Hashemi SA, Simani S, Behzadi R, Amini M, Kavoosian S, Maghsoudi F: Comparison of animal rabies from Northern Provinces of Iran referred to the Amol Research Center (ARC) during 2007. Internet Journal of Microbiology. 2009; 6(1): 1-7.
60. Amini M, Nahrevanian H, Farahmand M, Khatami S, Mirkhani F, Javadian S: Immuno-biochemical variation in susceptible BALB/c and resistant C57BL/6 mice infected with Iranian strain of cutaneous leishmaniasis; Leishmania major MRHO/IR/75/ER. Internet Journal of Infectious Diseases, 2009; 7(1): 1-4.
61. Rustaiyan A, Nahrevanian H, Kazemi M: A New Antimalarial Agent; Effect of Extracts of Artemisia diffusa against Plasmodium berghei. Pharmacognosy Magazine, 2009; 4(17): 1-7.
62. Amini M, Nahrevanian H, Farahmand M: Pathogenicity variations of susceptibility and resistance to Leishmania major MRHO/IR/75/ER strain in BALB/c and C57BL/6 mice. Iranian Journal of Parasitology, 2008; 3(4): 51-59.
63. Farahmand M, Assmar M, Nahrevanian H, Farzanehnejad Z, PiazaK N: Cutaneous leishmaniasis in patients referred to the Pasteur Institute of Iran during 2003-2006. Internet Journal of Parasitic Diseases, 2008; 3(2): 1-7.
64. Esfandiari B, Youssefi MR, Nahrevanian H, Keighobadi M, Aghvami Amoli Sh, Ziapour P: Incidence of Pediculosis in patients referring to Shemiranat Health Center, Tehran during 2002 to 2006. Internet Journal of Parasitic Diseases, 2008; 3(1): 1-6.
65. Nahrevanian H, Gholizadeh J, Farahmand M, Assmar M: Patterns of co-association of C-reactive protein and nitric oxide in malaria in endemic areas of Iran. Memórias Do Instituto Oswaldo Cruz, 2008; 103(1): 39-44.
66. Nahrevanian H, Assmar M: Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran. Journal of Microbiology Immunology & Infection, 2008; 41(1): 74-77.
67. Farahmand M, Nahrevanian H, Assmar M, Mohebali M, Zarei Z: Expression of A2 proteins in amastigotes of Leishmania infantum produced from canine isolates collected in the district of Meshkinshahr, in north–western Iran. Annals of Tropical Medicine and Parasitology, 2008; 102(1): 81-84.
68. Esfandiari B, Youssefi MR, Keighobadi M, Nahrevanian H: In vivo evaluation of anti-parasitic effects of Artemisia absinthium extracts on Syphacia parasite. Internet Journal of Parasitic Diseases, 2007; 2(2): 1-5.
69. Hashemi SA, Esfandiari B, Fayaz A, Nahrevanian H, Behzadi R, Kavoosian S, Ziapour SP, Ghobadi-rad S, Maghsoudi F: Investigation on animal and human rabies in cases from Mazandaran and Golestan provinces referred to the Amol Research Center, Northern Iran in 2003–2005. Internet Journal of Microbiology. 2007; 4(1): 1-4.
70. Nahrevanian H, Farahmand M, Aghighi Z, Assmar M, Amirkhani A: Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER; An Iranian strain of cutaneous leishmaniasis. Experimental Parasitology, 2007; 116(3): 233-240.
71. Nahrevanian H, Assmar M, Ghorbani Samin M: Cryptosporidiosis among immunocompetent patients with gastroenteritis in Tehran, I. R. Iran; A comparison with other enteropathogenic parasites. Journal of Microbiology Immunology & Infection, 2007; 40(2): 154-156.
72. Nahrevanian H: Immune effector mechanisms of nitric oxide pathway in malaria: Cytotoxicity versus cytoprotection. Brazilian Journal of Infectious Diseases, 2006; 10(4): 283-292.
73. Nahrevanian H, Assmar M: A case report of Cryptosporidiosis and Isosporiasis in AIDS patients in Iran, The Journal of Tropical Medicine & Parasitology, 2006; 29(1): 33-36.
74. Nahrevanian H, Gholizadeh J, Farahmand M, Assmar M, Sharifi K, Ayatollahi Mousavi SA, Abolhassani M: Nitric oxide induction as a novel immunoepidemiological target in malaria-infected patients from endemic areas of the Islamic Republic of Iran. Scandinavian Journal of Clinical & Laboratory Investigation, 2006; 66(3): 201-210. Nahrevanian H, Dascombe MJ: Simultaneous increases in immune competent cells and nitric oxide in the spleen during Plasmodium berghei infection in mice. Journal of Microbiology Immunology & Infection, 2006; 39(1): 11-17.
75. Nahrevanian H, Gholizadeh SJ, Farahmand M, Aghighi Z, Assmar M, Abolhassani M: Reactive nitrogen intermediate production and tolerance variability in different mouse strains after in vivo treatment with lipopolysaccharide from Salmonella abortus equi. Journal of Microbiology Immunology & Infection, 2005; 38(3): 164-168.
76. Nahrevanian H: Nitric oxide and reactive nitrogen intermediates are released by immune response during malaria infection. Journal of the Communicable Diseases, 2004; 3(3): 23-26.
77. Assmar M, Terhovanessian A, Nahrevanian H, Yassaei F, Esmaeili AR: Molecular detection of congenital toxoplasmosis by nested- PCR in Iran. Journal of the Communicable Diseases, 2004; 3(3): 27-29.
78. Nahrevanian H: The penetration of Plasmodium into red blood cell is a protective mechanism of malaria parasite against high levels of accumulated nitric oxide in blood circulation. Journal of Parasitic Diseases, 2004; 28(2): 83-89.
79. Assmar M, Yassaei F, Terhovanessian A, Esmaeili AR, Nahrevanian H, Hassan N, Farzaneh Nezhad Z, Naddaf SR: Prenatal diagnosis of congenital Toxoplasmosis: validity of PCR using amniotic fluid against indirect flouroscent antibody assay in mothers. Iranian Journal Public Health, 2004; 33(1): 1-4.
80. Nahrevanian H: Nitric oxide involvement during malaria infection; Immunological concepts, mechanisms and complexities; A novel review. The Journal of Tropical Medicine & Parasitology, 2004; 27(2): 93-101.
81. Nahrevanian H: Direct monitoring of in situ and in vitro nitric oxide release in the brain during malaria infection with Plasmodium berghei N/13/1A, The Journal of Tropical Medicine & Parasitology, 2004; 27(1): 1-6.
82. Assmar M, Terhovanessian A, Jahani MR, Nahrevanian H, Amirkhani A, Piazak N, Esmaeili AR, Farahmand M, Zare M: Molecular Epidemiology of Malaria Disease in Endemic Areas of Iran. Southeast Asian Journal Tropical Medicine & Public Health, 2003; 34(S2): 15-19.
83. Nahrevanian H, Dascombe MJ: The role of nitric oxide and its up/downstream molecules in malaria: cytotoxic or preventive? Southeast Asian Journal Tropical Medicine & Public Health, 2003; 34(S2): 44-50.
84. Nahrevanian H, Dascombe MJ: Reactive nitrogen intermediate (RNI) levels inside and outside Plasmodium infected red blood cells in murine malaria, The Journal of Tropical Medicine & Parasitology, 2003; 26(1): 13-19.
85. Dascombe MJ, Nahrevanian H: Pharmacological assessment of the role of nitric oxide in mice infected with lethal and nonlethal species of malaria, Parasite Immunology, 2003; 25(3): 149-159.
86. Nahrevanian H, Dascombe MJ: Expression of inducible nitric oxide synthase (iNOS) mRNA in target organs of lethal and non-lethal strains of murine malaria, Parasite Immunology, 2002; 24(9-10): 471-478.
87. Nahrevanian H, Dascombe MJ: Nitric oxide and reactive nitrogen intermediates during lethal and non-lethal strains of murine malaria, Parasite Immunology, 2001; 23: 491-501.
88. Assmar M, Milaninia A, Amirkhani A, Yadegari D, Forghanparast K, Nahrevanian H, Piazak N, Esmaeli AR, Hovanesian A, Valadkhani Z: Sero-epidemiological investigation of Fascioliasis in northern Iran, Medical Journal of Islamic Republic of Iran, 1991; 5(1,2): 23-27.